ExodusPoint Capital Management’s Abiomed Inc ABMD Stock Holding History

ExodusPoint Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,666	Closed	-$868K	–	2761
2021 Q3	$868K	Buy	2,666 +1,797	+207%	+$609K	0.01%	1093
2021 Q2	$271K	Buy	+869	New	+$267K	﹤0.01%	1801
2020 Q3	–	Sell	-12,835	Closed	-$3.1M	–	2372
2020 Q2	$3.1M	Buy	12,835 +10,283	+403%	+$2.06M	0.08%	282
2020 Q1	$370K	Sell	2,552 -7,209	-74%	-$1.2M	0.02%	589
2019 Q4	$1.67M	Buy	+9,761	New	+$1.81M	0.03%	390
2019 Q3	–	Sell	-2,008	Closed	-$523K	–	1727
2019 Q2	$523K	Sell	2,008 -815	-29%	-$216K	0.02%	450
2019 Q1	$806K	Buy	+2,823	New	+$938K	0.06%	228

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ExodusPoint Capital Management's ABMD Position: Q4 2021 in Review

ExodusPoint Capital Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 2,666 shares — an estimated $868K sold.

ExodusPoint Capital Management first reported a position in ABMD in Q1 2019 and held it in 7 quarters. The position peaked at $3.1M in Q2 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

ExodusPoint Capital Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 2,666 Abiomed Inc shares in Q4 2021, an estimated $868K.
ExodusPoint Capital Management first reported a position in Abiomed Inc in Q1 2019 and held it in 7 quarters.
ExodusPoint Capital Management's Abiomed Inc position peaked at $3.1M in Q2 2020.
496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.